Jamieson Wellness (TSE:JWEL – Get Free Report) was downgraded by stock analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a report issued on Friday,BayStreet.CA reports. They currently have a C$45.75 price target on the stock, up from their prior price target of C$45.00. Stifel Nicolaus’ target price would indicate a potential upside of 0.28% from the company’s previous close.
Separately, Canadian Imperial Bank of Commerce cut Jamieson Wellness from an “outperformer” rating to a “tender” rating and lifted their price objective for the company from C$44.00 to C$45.75 in a research report on Friday. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of C$45.30.
Check Out Our Latest Report on Jamieson Wellness
Jamieson Wellness Trading Up 9.9%
Jamieson Wellness (TSE:JWEL – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share for the quarter. Jamieson Wellness had a net margin of 8.71% and a return on equity of 15.25%. The firm had revenue of C$233.84 million for the quarter. Equities analysts anticipate that Jamieson Wellness will post 2.1438892 earnings per share for the current fiscal year.
About Jamieson Wellness
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.
See Also
- Five stocks we like better than Jamieson Wellness
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
